Fertility issues following hematopoietic stem cell transplantation

  title={Fertility issues following hematopoietic stem cell transplantation},
  author={Andr{\'e} Tichelli and Alicia Rov{\'o}},
  journal={Expert Review of Hematology},
  pages={375 - 388}
With the improvement of the outcome, the number of long-term survivors of hematopoietic stem cell transplantation (HSCT) is continuously increasing. However, there is still a high burden of late morbidity and mortality. Two-thirds of the transplant survivors develop at least one late effect interfering with their physical or psychological health. Infertility is common after myeloablative HSCT conditioned with total body irradiation and high doses of gonadotoxic drugs. Other factors, such as the… 

Preservation of fertility in patients with hematological malignancies.

Oncofertility is the medical field that bridges oncology and reproduction that seeks to give healthcare providers and patients the opportunity to optimize residual fertility through shared decision-making while always remaining aware of the rapidly progressing developments in reproductive medicine.

Indicators of male fertility potential in adult patients with beta-thalassemia major: a comparative study between patients undergone allogeneic stem cell transplantation and transfusion-dependent patients

Thalassemia patients undergone allogeneic HSCT have lower fertility potential, mainly in sperm parameters compared with patients treated with blood transfusion and chelation, which is important for thalassemic patients considering HSCT.

Special Care of Blood and Marrow Hematopoietic Cell Transplant Recipient

Hematopoietic cell transplantation (HCT) has evolved into one of the most effective therapeutic modalities for the treatment of neoplastic, immunologic, and genetic disorders in pediatric and adult

The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders

Future challenges include improvements in safety of HSCT, particularly in cardiac assessment of systemic sclerosis patients, cost–benefit analyses of HS CT compared to standard therapy and establishment of centres of excellence to continue to enhance the safety and benefit of this exciting new therapy.

Fertility maintenance in male oncological patients: current state and future perspectives.

It is deemed that fertility maintenance should be an integral part of the health care in oncological patients in reproductive age and a practical guide through the process of sperm cryopreservation and subsequent in vivo or in vitro fertilisation is presented.

Hematopoietic stem cell transplantation in children with Griscelli syndrome: A single‐center experience

The present study shows successful transplant outcome without long‐term neurologic sequelae in patients with GS2 who underwent HSCT from HLA‐related donors.

Endocrine and Metabolic Disorders after Hematopoietic Cell Transplantation

  • A. Paviglianiti
  • Medicine, Biology
    Turkish journal of haematology : official journal of Turkish Society of Haematology
  • 2019
The aim of this article is to describe metabolic dysfunctions occurring in patients who underwent allogeneic cell transplantation.

Childhood reproductive hormone levels after pediatric hematopoietic stem cell transplantation in relation to adult testicular function

Although reproductive hormone levels from mid-puberty indicated adult testicular function, prolonged follow-up into adulthood is needed in patients, including clinical examination, reproductive hormone analysis, and semen sample for patients interested in their fertility potential.

Hematopoietic Cell Transplantation and Utilization of Fertility Preservation Services.

Endocrine and Metabolic Disorders After Hematopoietic Stem Cell Transplantation Annalisa Paviglianiti Metabolic Diseases in Hematology

The aim of this article is to describe metabolic dysfunctions occurring in patients who underwent allogeneic cell transplantation.



Late complications after hematopoietic stem cell transplantation

Awareness on long-term effects after HSCT is crucial to provide adapted pretransplant counseling, and recommendations for post-transplant screening, prevention and early treatment.

Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

For the first time, ongoing graft-versus-host disease has been shown to be the most relevant adverse factor for sperm recovery, particularly in patients conditioned without total body irradiation.

Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence

In light of the significant proportion of HSCT patients reviewed with impaired fertility, fertility conservation procedures should be considered for all patients undergoing HSCT, particularly those receiving TBI or BU-based preparative regimens.

Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regime.

The present study aimed to document the effect of RIC on ovarian function and reported low rate of nonrelapse mortality and low incidence of graftversus-host disease with a RIC protocol based on a fludarabine, melphalan, and campath-1H combination.

How does bone marrow transplantation affect ovarian function and fertility?

Despite a lack of literature on long-term follow-up of fertility after BMT in large populations, it is clear that the risk of ovarian damage and POF is very high and fertility preservation options should therefore be discussed with all patients having to undergo BMT.

Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling

The overall high incidence of azoospermia supports the indication for semen cryopreservation in young patients undergoing BMT and underline a need to collect further data through prospective multi-center studies.

Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.

Men who are long-term survivors, who were younger than 25 years at HSCT, and who apparently do not have chronic GvHD have a reasonable likelihood of spermatogenesis even when conditioned with standard-dose TBI.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

  • A. LorenE. Chow N. Majhail
  • Medicine, Biology
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2011

Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up

  • S. Bhatia
  • Medicine
    Expert review of hematology
  • 2011
It is critically important that there is standardized follow-up of HSCT survivors at high risk for post-HSCT complications, as these patients are at a fourfold to ninefold increased risk of late mortality for as long as 30 years from HSCT.

Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births

Ovarian cortex cryopreservation should be offered before gonadotoxic chemotherapy in all cases where there is a high risk of POF and where emergency IVF is not possible, according to a review of available options.